Drug Trial Radar · NCT04532749
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
Last checked: Nov 20, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
212
Actual
Start
Sep 15, 2020
Primary completion
May 24, 2022
Study completion Jul 14, 2022
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Aug 31, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy of Seltorexant compared with placebo as adjunctive therapy to an antidepressant in improving depressive symptoms in participants with major depressive disorder with insomnia symptoms (MDDIS) who have had an inadequate response to current antidepressant therapy with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI).
Conditions
- Depressive Disorder, Major
Interventions
SeltorexantDrug
Participants will receive Seltorexant tablets.
PlaceboDrug
Participants will receive matching placebo tablets.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Day 43 in Montgomery-Asberg Depression Rating Scale (MADRS) Total ScoreTime frame: Baseline (Day 1), Day 43
Locations
80 sites in 10 countries. Site status is shown where the registry gives one.
Altea Research Institute
Phoenix, Arizona
Preferred Research Partners
Little Rock, Arkansas
Behavioral Research Specialists LLC
Glendale, California
Sun Valley Research Center
Imperial, California
Alliance for Research
Long Beach, California
Excell Research Inc
Oceanside, California
California Neuroscience Research Medical Group, Inc.
Sherman Oaks, California
Pharmax Research Clinic Inc
Miami, Florida
Innova Clinical Trials
Miami, Florida
Harmony Clinical Research Inc
North Miami Beach, Florida
Medical Research Group of Central Florida
Orange City, Florida
Synexus Research Orlando
Orlando, Florida
Stedman Clinical Trials
Tampa, Florida
Compass Research LLC-Bioclinica Research
The Villages, Florida
Synexus Clinical Research US Inc
Atlanta, Georgia
Rush University Medical Center
Chicago, Illinois
Uptown Research Institute, LLC
Chicago, Illinois
Phoenix Medical Research, Inc.
Prairie Village, Kansas
Michigan Clinical Research Institute
Ann Arbor, Michigan
Eastside Comprehensive Medical Services
New York, New York
Community Research Management Associates, Inc.
Cincinnati, Ohio
Patient Priority Clinical Sites LLC
Cincinnati, Ohio
Intend Research
Norman, Oklahoma
IPS Research Company
Oklahoma City, Oklahoma
InSite Clinical Research LLC
DeSoto, Texas
Pillar Clinical Research, LLC
Richardson, Texas
Clínica Privada Banfield S.A
Banfield, Argentina
STAT Research S A
Buenos Aires, Argentina
NOVAIN Neurociencias Group
Buenos Aires, Argentina
Fundacion para el Estudio y Tratamiento de las Enfermedades Mentales
Buenos Aires, Argentina
CEN Consultorios Especializados en Neurociencias
Córdoba, Argentina
Instituto Medico DAMIC
Córdoba, Argentina
Sanatorio Prof. Leon S. Morra
Córdoba, Argentina
INSA Instituto de Neurociencias San Agustín
La Plata, Argentina
C I A P Centro de investigacion y Asistencia en Psiquiatria
Rosario, Argentina
Clinica Mayo de UMCB
San Miguel de Tucumán, Argentina
Psicomed Estudios Medicos
Antofagasta, Chile
BioMedica Research Group
Santiago, Chile
CeCim - Centro de Estudios Clinicos e Investigacion Medica
Santiago, Chile
Hospital Dr Hernan Henriquez Aravena
Temuco, Chile
Showing 40 of 80 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.